Biologically Driven In Vivo Occlusion Design Provides a Reliable Experimental Glaucoma Mouse Model

Viscobeads induce sustained ocular hypertension of 21.4 mm Hg for at least 8 weeks in mice, causing significant retinal ganglion cell loss and visual impairment.

• Why it matters: Reliable long-term models of glaucoma are essential for understanding disease mechanisms and testing treatments, but current microbead models lack durability and stability.
• What they did: Researchers developed an injectable, biologically inspired Viscobeads platform combining non-degradable and biodegradable components, enabling consistent intraocular pressure elevation in mice.
• The result: This materials-driven approach provides a stable, chronic glaucoma model that supports gene screening and reveals early retinal dysfunction, advancing therapeutic research and understanding of disease progression.